article thumbnail

DTC Study: Marketers misaligned with online health seeker needs

World of DTC Marketing

TV spots are the number one way people learn about new pharma products. 3hree: Pharma product websites are not listed as a top online health resource even when looking for information on a specific product. 8ight: The number one way people learn about new pharma products is via TV.

Marketing 279
article thumbnail

Uniqueness if pharma DTC

World of DTC Marketing

Pharma DTC marketing is unique, and drug marketers need to think more about the journey from awareness to requesting an Rx. In addition, the patient journey is different for each product category and audience. The hottest pharma product is Lilly’s diabetes drug, hyped by the media as helping patients lose weight.

Marketing 210
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Innate Pharma and Takeda sign licence deal to develop ADCs for coeliac disease

Pharmaceutical Technology

Innate Pharma has signed an exclusive licence agreement with Takeda to enable research and development of antibody drug conjugates (ADCs) against an undisclosed target, primarily focusing on coeliac disease. In addition, Innate will receive royalties on possible net sales of any commercial product to be developed under the licence.

article thumbnail

Pipelinepharma marketplace records quadruple growth over a single year

Pharma Mirror

As a response to increasing demand, Pipelinepharma will introduce biosimilar drugs into a separate category. We are building upon our vision to become the world’s leading B2B pharma product platform. While quantity is sometimes a quality in itself, our product listings are curated by.

article thumbnail

Bayer triples sales forecast for prostate cancer drug Nubeqa

pharmaphorum

Bayer now says it expects to make €3 billion in sales for its prostate cancer treatment Nubeqa, up from an earlier estimate of €1 billion, after reviewing new data for the drug in metastatic hormone-sensitive tumours. The post Bayer triples sales forecast for prostate cancer drug Nubeqa appeared first on.

Sales 98
article thumbnail

Bayer sells testosterone drug rights to Grünenthal for €500m

pharmaphorum

The group is facing the threat of competition from big-selling pharma products Eylea (aflibercept) for ophthalmic diseases and anticoagulant Xarelto (rivaroxaban) in the coming years, and is pivoting to growth areas to try to ride out that loss in revenues.

Drugs 97
article thumbnail

The right balance in DTC: Tv versus digital ads

World of DTC Marketing

The shift to digital advertising doesn’t make sense when pharma product websites don’t meet consumers’ needs. TV is still the best way to introduce a new product provided it has a big audience. There is a direct correlation between pharma product website traffic and TV ads for new products.